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Cytochromes P450 can catalyse hydroxylation reactions
that are of considerable potential synthetic value, but a
number of practical difficulties have hitherto prevented
their use for this purpose. Recent advances, including
intelligently designed laboratory evolution experiments,
promise to overcome these obstacles, and to add P450s
to the enzymatic armoury of the chemist.
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The advantages of enzymes as catalysts of chemical trans-
formations are increasingly widely recognised. Not only do
they make it possible to carry out reactions under mild,
environmentally friendly conditions — for example in
water at room temperature — but they also often show
remarkable regio- and stereospecificity. For simple
enzymes such as hydrolases, a range of practical applica-
tions has already been realised, but other enzymes, notably
redox enzymes that require additional protein cofactors for
their function, present a greater challenge. A particularly
important group of enzymes in this category are the
cytochrome P450 monooxygenases (P450s). These ubiqui-
tous enzymes catalyse the insertion of one atom of molecu-
lar oxygen into a substrate, with concomitant reduction of
the other atom to water. They play essential roles in the
biosynthesis of prostaglandins and steroids, as well as of
numerous secondary metabolites in plants and microorgan-
isms, and in the detoxification of a wide range of foreign
compounds, including both drugs and chemical pollutants.
From the synthetic point of view, their ability to hydroxy-
late unactivated carbons and, for example, their ability to
produce pure enantiomers of epoxides are of particular
interest. At least 600 P450s are known, with a wide range of
substrate specificity, making them, potentially, very attrac-
tive synthetic reagents. There are, however, some impor-
tant obstacles that must be overcome before this potential
can be realised: all P450s require at least one redox partner
protein, and many of these are membrane-bound and rela-
tively unstable. Several recent papers have reported valu-
able steps towards overcoming these problems, notably
recent reports by Frances Arnold and colleagues [1,2], who
describe the use of ‘directed evolution’ to produce mutants
of the bacterial P450cam that catalyse naphthalene hydrox-
ylation using hydrogen peroxide as the source of oxygen,
thus bypassing the need for cofactors.
The catalytic cycle of P450s is shown in Figure 1; physio-
logically, the two electrons required at distinct steps in
this cycle are ultimately derived from the nicotinamide
coenzymes NADH or NADPH through a flavoprotein
reductase. In the monooxygenase system of the mam-
malian endoplasmic reticulum, for example, which is of
crucial importance in drug metabolism (‘class II’ P450s),
electrons are transferred directly from the flavoprotein to
the P450. In other cases, including most bacterial P450s
and the mammalian mitochondrial enzymes involved in
steroid biosynthesis (‘class I’ P450s), an iron–sulphur
protein mediates the electron transfer from the flavo-
protein to the P450. Considerable advances have been
made in the development of systems for regeneration of
the expensive nicotinamide cofactors for application in
bio-transformations, but these all involve a further protein
and an additional substrate. A system for using a
cytochrome P450 in a synthesis therefore appears to
involve three or four proteins, together with substrates and
cofactors that would need to be separated from the desired
product — not an attractive proposition!
In recent years, a number of steps have been taken to sim-
plify this system. First, methods have been developed for
the expression of the membrane-bound mammalian
enzymes and their purification in the presence of minimal
amounts of detergent. Second, it has proved possible to
link the components of the monooxygenase system
together. This occurs in nature in the form of cytochrome
P450 BM3, a bacterial fatty acid hydroxylase that contains
both a cytochrome P450 domain and a flavoprotein
NADPH-cytochrome P450 reductase domain in a single
polypeptide chain [3]. Artificial ‘fusion proteins’ of this
kind have been successfully made for the two-component
class II monooxygenases [4] and even for the three-compo-
nent class I system [5], and shown to have full catalytic
activity. We therefore have a single protein able to carry out
the monooxygenase reaction, a useful simplification, but
we are still faced with the need to supply and regenerate
the reduced nicotinamide cofactor. Clearly what is required
is to dispense with the need for the cofactor altogether,
supplying the electrons in some other way, and Joo et al.
[1,2] have done so by making use of the so-called ‘peroxide
shunt’ (Figure 1). Addition of hydrogen peroxide (or an
organic peroxide) to the initial enzyme–substrate complex
supplies both the electrons and the oxygen atom required
to form the reactive iron–oxygen intermediate, the species
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which inserts the oxygen atom into the substrate. This has
the desired result of removing the need for supplying elec-
trons from the redox partner, ultimately from NAD(P)H.
The use of peroxide in this way is inefficient, however, and
carries with it the danger of inactivation of the enzyme.
Although the structure of P450cam, the specific enzyme
studied by Joo et al. [1,2], has been known for some years
[6], too little is known of the mechanistic details to allow
the design of mutations to improve the efficiency of this
process. It was necessary, therefore, to use random mutage-
nesis and screening or ‘laboratory evolution’.
It is well known that the key to success in such an endeav-
our is the design of an appropriate and efficient screen,
and that devised by Arnold and her colleagues [1,2] inge-
niously made dual use of hydrogen peroxide, both as sub-
strate and as a detection reagent for the product(s). The
objective was to obtain mutants of P450cam able to effi-
ciently hydroxylate naphthalene using the peroxide shunt
pathway. The natural substrate of this enzyme is camphor,
and the wild-type enzyme shows very little activity against
naphthalene, although this can be increased significantly
by a single-site mutation in the substrate-binding pocket
[6]. The screen used (Figure 2) depended on the fact that
the reaction products, monohydroxylated and dihydroxy-
lated naphthalenes, can be oxidatively coupled by horse-
radish peroxidase (HRP) and hydrogen peroxide to give
fluorescent dimers and higher polymers. Fluorescence
imaging of a multiwell plate containing colonies of
Escherichia coli expressing both mutants of P450cam, pro-
duced randomly by mutagenic polymerase chain reaction
(PCR), and HRP provided, therefore, an efficient means
of identifying mutants that had increased activity against
naphthalene under these conditions. Approximately
200,000 colonies were screened in this way, and of these
about 5,000 showed activity at least as great as the wild-
type enzyme. The most active colony identified had 11-
fold higher activity than wild type, and also showed
greater activity in the assay against the unrelated substrate
3-phenyl-propionate, suggesting that the screen was
indeed identifying mutants in which the peroxide shunt is
more efficient, as well as those better able to use naphtha-
lene as a substrate. In vitro recombination (DNA shuf-
fling — see below) of the genes coding for five of the
high-activity mutants identified in the first screen led to a
further increase in activity to a maximum of 20-fold
greater than that of the wild-type enzyme. An additional
benefit of the screen used was that the colour of the fluo-
rescence, reflecting the nature of the polymer formed, in
turn reflected the regiospecificity of the initial hydroxyla-
tion(s); the range of colours produced clearly showed that
many of the mutants generated had regiospecificities dif-
ferent from that of the wild-type enzyme.
There are numerous examples in the literature of the alter-
ation of the substrate specificity, and sometimes the
regiospecificity, of cytochromes P450 — not only the bac-
terial P450cam [7,8] and P450 BM3 [9–11] but also mam-
malian P450s [12,13] — using site-directed mutagenesis
informed by three-dimensional structures or homology
models of the enzymes. For example, single residue substi-
tutions in P450 BM3 were able to favour hydroxylation of
alkyl trimethylammonium compounds rather than fatty
acids [9], and to convert the regiospecificity of saturated
fatty acid hydroxylation from (ω–1 + ω–2 + ω–3) to virtu-
ally exclusively ω-hydroxylation [10]. Three of the
P450cam mutants identified by Joo et al. [1,2] in the first
round of screening that had at least fivefold greater activity
than the wild-type were sequenced. All were found to have
a lysine for glutamate substitution at position 133; two had
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Figure 1
The electron transfer chains of class I and
class II cytochromes P450, and the catalytic
cycle common to both classes of enzyme,
illustrating the ‘peroxide shunt’ exploited by
Joo et al. [1,2]. 
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additional mutations, in one case Arg280→Leu, in the
other Cys242→Phe. Residue 242 lies at the edge of the
haem pocket, on the proximal side, and it is conceivable
that the substitution at this position helps to protect the
enzyme from inactivation by peroxide [1]. The other two
residues are near, but not in, the substrate-binding pocket,
and the origins of the modest effects of these substitutions
on catalytic activity are far from clear. This is a salutary
reminder of the importance of subtle, long-range effects on
enzyme specificity and activity, and of the difficulty in pre-
dicting these even in an enzyme as well studied as
P450cam. It also demonstrates the power of ‘laboratory
evolution’ to improve the desired characteristics of an
enzyme, precisely because it does not depend on the ade-
quacy of our understanding of the contribution of individ-
ual residues to determining these characteristics, be they
catalytic activity, specificity or thermal stability [14,15].
Two important steps towards the application of P450s in
organic synthesis have therefore been taken. First, it is
clear that the activity, substrate specificity and regiospeci-
ficity of these enzymes can readily be modified by muta-
genesis — either by site-directed mutagenesis or by
random mutagenesis and screening. Second, the work of
Arnold and her colleagues [1,2] offers one route for over-
coming the need for a cofactor for these enzymes. What
are the prospects for further improvements? The modest
increases in activity of 20-fold reported by Joo et al. [1,2]
were achieved after only two rounds of mutation and
selection, and it seems certain that much larger increases
will be achievable, notably by further rounds of DNA
shuffling. Work by Arnold and by others [16,17] has shown
the power of DNA shuffling (in vitro recombination) in
laboratory evolution. This method involves the generation
of chimeric genes from a pool of related genes — for
example mutants of the gene of interest — either by frag-
mentation and reassembly or by a staggered, or inter-
rupted, extension process. Individual mutations are thus
‘shuffled’ into a wide range of combinations, dramatically
increasing the diversity of the population of genes avail-
able for selection, and hence the likelihood of obtaining a
gene product with the desired characteristics. DNA shuf-
fling can be carried out not only using a pool of mutants of
a specific gene, but also using a pool of homologous genes
from different species — for example, this approach has
been used to speed up dramatically the laboratory evolu-
tion of specificity in β lactamases [18]. Given the enor-
mous repertoire of P450 genes encoding enzymes
catalysing the same basic reaction but with differing speci-
ficity, there would seem to be exciting prospects for alter-
ing specificity in this way. For example, one could
envisage introducing the specificity of the relatively
unstable membrane-bound mammalian enzymes into
stable, soluble bacterial enzymes such as P450cam or P450
BM3; the work of Arnold and her colleagues [1,2] is an
illustration of the ingenuity that will be required to devise
appropriate screens. The vast majority of laboratory evolu-
tion experiments involve expression of the gene product
and selection for the desired activity in a bacterial cell.
They are, therefore, likely to be at least much less effi-
cient, if not impossible, in cases where the substrate or the
product are toxic to the cell, as might be the case for some
organic intermediates; Tawfik and Griffiths [19] have
recently described an elegant in vitro alternative, however,
where an individual gene is transcribed and translated in
the aqueous compartment of a water-in-oil emulsion, this
cell-like compartment providing the necessary link
between the gene and its product to allow laboratory evo-
lution to be carried out.
There are great opportunities for generating P450s with
desired catalytic functions. There are also promising alter-
natives to the peroxide shunt as a means of avoiding the
need for a cofactor. Estabrook and his colleagues [20] have
shown that it is possible to drive P450 hydroxylation reac-
tions electrochemically using a P450–reductase fusion
protein of the kind discussed above, with a platinum elec-
trode and cobalt sepulchrate as a mediator; this has been
used successfully for ω-hydroxylation of fatty acids [21]
and for the synthesis of 17α-hydroxyprogesterone [22].
More recently, we have shown that electrons can be
injected directly into P450s, without the need for the
flavoprotein, using a modified gold electrode (A. Abbott,
F. Almed, P.M. Cullis, W.U. Primrose and G.C.K.R.,
unpublished observations; [23]); this has been applied to
both P450 BM3 and a number of mammalian P450s. It
remains to be seen whether the application of
cytochromes P450 in organic synthesis will be commer-
cially viable, but the initial practical obstacles have been
overcome, and the prospects are much brighter than they
were only a few years ago.
Minireview  Doing chemistry with P450s Roberts    R271
Figure 2
The basis of the screen developed by Joo et al. [1,2], showing the dual
use of hydrogen peroxide, both in supplying oxygen and electrons to the
P450-catalysed reaction and as part of the product detection system.
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